(Q48604084)

13 February 2018

title

Oxidative modification of glutamine synthetase by amyloid beta peptide (English)

1 reference

13 February 2018

Oxidative Modification of Glutamine Synthetase by Amyloid Beta Peptide (English)

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

21 November 2024

author name string

M. Y. Aksenov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9350431

21 November 2024

M. V. Aksenova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9350431

21 November 2024

J. M. Carney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9350431

21 November 2024

D. A. Butterfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9350431

21 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9350431

21 November 2024

publication date

1 September 1997

1 reference

13 February 2018

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9350431

full work available at URL

21 November 2024

http://www.tandfonline.com/doi/pdf/10.3109/10715769709065765

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

21 November 2024

published in

Free Radical Research

1 reference

13 February 2018

volume

27

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

267-281

1 reference

13 February 2018

The molecular pathology of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Effects of injected Alzheimer beta-amyloid cores in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Carbonyl assays for determination of oxidatively modified proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Glutamine Synthetase: Glial Localization in Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Reaction of astrocytes in the gerbil hippocampus following transient ischemia: immunohistochemical observations with antibodies against glial fibrillary acidic protein, glutamine synthetase, and S-100 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Metal-catalyzed oxidation of Escherichia coli glutamine synthetase: correlation of structural and functional changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

The role of iron in beta amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Protein hydroperoxides can give rise to reactive free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Transferrin C2 and Alzheimer's disease: another piece of the puzzle found?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Amyloid peptides are toxic via a common oxidative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715769709065765

The American Journal of Pathology

21 January 2018

3

148

259

Fukumoto H.

1996

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

21 November 2024

7

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons

21 November 2024

10

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis

21 November 2024

15

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

21 November 2024

17

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

21 November 2024

18

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

21 November 2024

19

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Determination of carbonyl content in oxidatively modified proteins

21 November 2024

21

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Oxidative modification of Escherichia coli glutamine synthetase. Decreases in the thermodynamic stability of protein structure and specific changes in the active site conformation.

21 November 2024

30

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase.

21 November 2024

33

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Antibody probing of western blots which have been stained with india ink

21 November 2024

35

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease.

21 November 2024

36

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation

21 November 2024

37

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

21 November 2024

43

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

Purification and immunocharacterization of human brain glutamine synthetase and its detection in cerebrospinal fluid and serum by a sandwich enzyme immunoassay

21 November 2024

44

1 reference

https://api.crossref.org/works/10.3109/10715769709065765

21 November 2024

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018